ANDI’s primary objective is to promote and support health product R&D led by African institutions for diseases of high prevalence in the continent.
The African Network for Drugs and Diagnostics Innovation (ANDI) was launched in Abuja in 2008. Its goal is to promote and sustain African-led product R&D innovation through the discovery, development and delivery of affordable new tools, including those based on traditional medicines. ANDI also supports capacity and infrastructural development.
To promote and sustain African-led health product innovation to address African public health needs through efficient use of local knowledge, assembly of research networks, and building of capacity to support economic development.
Create a sustainable platform for R&D innovation in Africa to address Africa’s own health needs.
ANDI’s primary objective is to promote and support health product R&D led by African institutions for diseases of high prevalence in the continent. The expected outcome is the discovery, development and delivery of affordable new health tools including those based on traditional medicine, as well as the development of capacity and establishment of centers of research excellence.
CEO, Biovac InstituteRead More
Director, Centre for African Entrepreneurship and Leadership (CAEL) at University of Wolverhampton, UK
Professor of International Business at Offenburg University
Former President of the United Republic of Tanzania
Executive Secretary of the Economic Commission for Africa
Director of International Records Management Trust